Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Earnings for Alpha Tau Medical Ltd. (DRTS)
Earnings in 2023 (TTM): $-29,141,000
According to Alpha Tau Medical Ltd.'s latest financial reports the company's current earnings (TTM) are $-29,141,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Alpha Tau Medical Ltd.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-29,141,000 | $-29,157,000 |
| 2022 | $-33,742,000 | $-33,762,000 |
| 2021 | $-27,264,000 | $-27,271,000 |
| 2020 | $-8,724,000 | $-8,882,000 |
| 2019 | $-8,318,000 | $-8,464,000 |